Add time:08/13/2019         Source:sciencedirect.com

ObjectivesA new radiotracer, 124I-epidepride, has been developed for the imaging of dopamine D2/3 receptors (D2/3Rs). 124I-Epidepride (half-life of 124I = 4.2 days) allows imaging over extended periods compared to 18 F-fallypride (half-life of 18 F = 0.076 days) and may maximize visualization of D2/3Rs in the brain and pancreas (allowing clearance from adjacent organs). D2/3Rs are also present in pancreatic islets where they co-localize with insulin to produce granules and may serve as a surrogate marker for imaging diabetes.

We also recommend Trading Suppliers and Manufacturers of epidepride (cas 107188-87-4). Pls Click Website Link as below: cas 107188-87-4 suppliers